AxoGen, Inc. Preannounces Estimated Fourth Quarter and Full Year 2016 Revenue
Jan 09, 2017 12:01 pm UTC| Business
Q4 Revenue will be at least $11.3 million, representing 45% growth over prior year 2016 Revenue will be at least $41.0 million, representing 50% growth over prior year ALACHUA, Fla., Jan. 09, 2017 -- AxoGen, Inc....
Jan 09, 2017 12:01 pm UTC| Business
Critical Phase 3 study design input received from U.S. Food and Drug Administration (“FDA”): Agreed to a randomized open-label, two-arm clinical study to include a LPCN 1107 arm and a comparator intramuscular (“IM”) arm...
Curis and Aurigene Extend Exclusivity Period of Immuno-Oncology and Precision Oncology Collaboration
Jan 09, 2017 12:00 pm UTC| Business
LEXINGTON, Mass., Jan. 09, 2017 -- Curis, Inc. (Nasdaq:CRIS), a biotechnology company focused on the development and commercialization of innovative and effective drug candidates for the treatment of cancer, today...
Southcross Energy Announces Leadership Change
Jan 09, 2017 12:00 pm UTC| Business
DALLAS, Texas, Jan. 09, 2017 -- Southcross Energy Partners, L.P. (NYSE:SXE) (“Southcross”) and Southcross Holdings LP (“Holdings”) announced today a consolidation of the roles of Chairman and Chief Executive Officer of...
Xeris Pharmaceuticals Announces Appointment of Paul R. Edick as President and CEO
Jan 09, 2017 12:00 pm UTC| Business
Austin, Texas, Jan. 09, 2017 -- Xeris Pharmaceuticals, Inc., a specialty biopharmaceutical company focused on the development and commercialization of novel formulations of injectable drugs, announced that Mr. Paul R....
Jan 09, 2017 12:00 pm UTC| Business
SANTA MONICA, Calif., Jan. 09, 2017 -- Opiant Pharmaceuticals, Inc. (“Opiant”) (OTCQB:OPNT), a specialty pharmaceutical company developing pharmacological treatments for substance use, addictive and eating disorders,...
Jan 09, 2017 12:00 pm UTC| Business
GAITHERSBURG, Md., Jan. 09, 2017 -- Emergent BioSolutions Inc. (NYSE:EBS) today announced preliminary unaudited 2016 financial results and guidance for 2017. Daniel J. Abdun-Nabi, president and chief executive officer...